Orlando Magic · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 17.9 | 9.3 | 3.7 | 1.7 | 14.7 | 1.0 | 1.3 | 1.7 | 2.0 | 4.0 |
| 50.0% |
| 1.0 |
| 4.3 |
| 23.1% |
| 2.3 |
| 3.0 |
| 77.8% |
| Last 5 | 5 | 14.2 | 8.4 | 2.6 | 1.4 | 12.4 | 1.2 | 0.8 | 1.4 | 1.8 | 3.8 | 47.4% | 0.8 | 3.4 | 23.5% | 2.4 | 3.6 | 66.7% |
| Last 10 | 10 | 23.0 | 8.7 | 2.7 | 2.1 | 13.5 | 1.4 | 0.7 | 1.5 | 2.4 | 5.7 | 42.1% | 0.7 | 3.7 | 18.9% | 1.8 | 3.1 | 58.1% |
| Last 20 | 20 | 27.9 | 13.6 | 3.2 | 3.0 | 19.8 | 1.8 | 0.8 | 1.4 | 3.4 | 6.8 | 51.1% | 1.4 | 4.9 | 28.6% | 2.5 | 3.2 | 75.4% |
| Season | 64 | 29.8 | 15.0 | 3.8 | 3.7 | 22.5 | 1.4 | 0.7 | 2.1 | 3.8 | 7.4 | 51.9% | 1.6 | 4.7 | 33.3% | 2.6 | 3.6 | 73.2% |
low rim finishing off the ball, low contested shots per minute, low offensive rebounding, high on-ball creation
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | ORL @ BOS | L | 19.0 | 13 | 3 | 1 | 1 | 1 | 2 | 5 | 9 | 55.6% | 1 | 4 | 25.0% | 2 | 3 | 66.7% | -13.0 |
| 2026-04-10 | ORL @ CHI | W | 18.6 | 8 | 3 | 2 | 2 | 1 | 0 | 3 | 12 | 25.0% | 2 | 7 | 28.6% | 0 | 0 | 0.0% | 1.0 |
| 2026-04-08 | ORL vs. MIN | W | 16.1 | 7 | 5 | 2 | 0 | 2 | 3 | 1 | 4 | 25.0% | 0 | 2 | 0.0% | 5 | 6 | 83.3% | 7.0 |
| 2026-04-06 | ORL vs. DET | W | 15.5 | 14 | 1 | 2 | 2 | 0 | 2 | 4 | 11 | 36.4% | 1 | 4 | 25.0% | 5 | 7 | 71.4% | -14.0 |
| 2026-03-07 | ORL @ MIN | W | 2.0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | 2.0 |
| 2026-03-05 | ORL vs. DAL | W | 23.8 | 8 | 3 | 3 | 2 | 0 | 0 | 3 | 12 | 25.0% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | 2.0 |
| 2026-02-26 | ORL vs. HOU | L | 23.1 | 8 | 1 | 2 | 1 | 0 | 2 | 3 | 12 | 25.0% | 2 | 6 | 33.3% | 0 | 1 | 0.0% | -7.0 |
| 2026-02-24 | ORL @ LAL | W | 30.5 | 8 | 4 | 4 | 3 | 2 | 2 | 4 | 13 | 30.8% | 0 | 2 | 0.0% | 0 | 4 | 0.0% | 2.0 |
| 2026-02-22 | ORL @ LAC | W | 36.4 | 11 | 2 | 1 | 1 | 0 | 2 | 4 | 9 | 44.4% | 1 | 4 | 25.0% | 2 | 4 | 50.0% | -8.0 |
| 2026-02-21 | ORL @ PHX | L | 44.9 | 10 | 4 | 4 | 1 | 1 | 2 | 4 | 12 | 33.3% | 0 | 5 | 0.0% | 2 | 2 | 100.0% | 8.0 |
| 2026-02-19 | ORL @ SAC | W | 31.2 | 20 | 3 | 3 | 3 | 0 | 1 | 8 | 13 | 61.5% | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 26.0 |
| 2026-02-11 | ORL vs. MIL | L | 24.7 | 13 | 3 | 3 | 1 | 0 | 2 | 5 | 10 | 50.0% | 3 | 5 | 60.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-02-09 | ORL vs. MIL | W | 34.1 | 26 | 5 | 2 | 2 | 1 | 1 | 8 | 13 | 61.5% | 2 | 6 | 33.3% | 8 | 9 | 88.9% | 13.0 |
| 2026-02-07 | ORL vs. UTA | W | 38.0 | 21 | 3 | 4 | 4 | 1 | 2 | 8 | 19 | 42.1% | 1 | 7 | 14.3% | 4 | 4 | 100.0% | -2.0 |
| 2026-02-05 | ORL vs. BKN | W | 27.6 | 18 | 2 | 5 | 1 | 1 | 0 | 6 | 12 | 50.0% | 2 | 5 | 40.0% | 4 | 5 | 80.0% | 18.0 |
| 2026-02-03 | ORL @ OKC | L | 28.4 | 10 | 6 | 3 | 1 | 2 | 2 | 5 | 16 | 31.3% | 0 | 6 | 0.0% | 0 | 0 | 0.0% | -21.0 |
| 2026-02-01 | ORL @ SAS | L | 29.8 | 11 | 1 | 2 | 2 | 0 | 2 | 4 | 12 | 33.3% | 2 | 5 | 40.0% | 1 | 1 | 100.0% | -24.0 |
| 2026-01-30 | ORL vs. TOR | W | 39.9 | 25 | 4 | 6 | 0 | 1 | 0 | 5 | 11 | 45.5% | 1 | 5 | 20.0% | 14 | 14 | 100.0% | 14.0 |
| 2026-01-28 | ORL @ MIA | W | 37.4 | 26 | 7 | 5 | 4 | 2 | 0 | 11 | 19 | 57.9% | 4 | 7 | 57.1% | 0 | 1 | 0.0% | 19.0 |
| 2026-01-26 | ORL @ CLE | L | 37.2 | 14 | 4 | 5 | 3 | 1 | 2 | 6 | 14 | 42.9% | 2 | 9 | 22.2% | 0 | 0 | 0.0% | -14.0 |
| 2026-01-24 | ORL vs. CLE | L | 39.9 | 16 | 5 | 5 | 2 | 1 | 2 | 6 | 12 | 50.0% | 3 | 7 | 42.9% | 1 | 2 | 50.0% | -6.0 |
| 2026-01-22 | ORL vs. CHA | L | 27.6 | 4 | 2 | 2 | 0 | 1 | 1 | 1 | 11 | 9.1% | 1 | 5 | 20.0% | 1 | 2 | 50.0% | -23.0 |
| 2026-01-18 | ORL @ MEM | L | 37.1 | 19 | 2 | 6 | 0 | 0 | 4 | 7 | 15 | 46.7% | 2 | 6 | 33.3% | 3 | 4 | 75.0% | -14.0 |
| 2026-01-15 | ORL @ MEM | W | 35.5 | 21 | 6 | 7 | 1 | 0 | 1 | 7 | 13 | 53.8% | 4 | 7 | 57.1% | 3 | 3 | 100.0% | 17.0 |
| 2026-01-11 | ORL vs. NOP | W | 36.1 | 26 | 5 | 7 | 3 | 0 | 4 | 9 | 10 | 90.0% | 3 | 4 | 75.0% | 5 | 7 | 71.4% | 17.0 |
| 2026-01-09 | ORL vs. PHI | L | 37.3 | 21 | 3 | 4 | 0 | 0 | 4 | 7 | 12 | 58.3% | 3 | 7 | 42.9% | 4 | 4 | 100.0% | -6.0 |
| 2026-01-07 | ORL @ BKN | W | 37.4 | 5 | 4 | 6 | 2 | 0 | 4 | 2 | 11 | 18.2% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-06 | ORL @ WAS | L | 20.5 | 6 | 5 | 4 | 0 | 1 | 4 | 3 | 10 | 30.0% | 0 | 5 | 0.0% | 0 | 0 | 0.0% | -19.0 |
| 2026-01-04 | ORL vs. IND | W | 35.5 | 27 | 3 | 10 | 1 | 4 | 1 | 8 | 16 | 50.0% | 3 | 7 | 42.9% | 8 | 10 | 80.0% | -3.0 |
| 2026-01-02 | ORL @ CHI | L | 33.3 | 18 | 2 | 7 | 2 | 1 | 3 | 8 | 16 | 50.0% | 2 | 5 | 40.0% | 0 | 0 | 0.0% | -10.0 |
| 2025-12-31 | ORL @ IND | W | 31.1 | 15 | 4 | 5 | 2 | 1 | 4 | 6 | 11 | 54.5% | 0 | 3 | 0.0% | 3 | 3 | 100.0% | 7.0 |
| 2025-12-29 | ORL @ TOR | L | 32.2 | 27 | 3 | 3 | 1 | 0 | 4 | 9 | 19 | 47.4% | 2 | 7 | 28.6% | 7 | 7 | 100.0% | -3.0 |
| 2025-12-27 | ORL vs. DEN | W | 30.1 | 38 | 6 | 5 | 2 | 0 | 1 | 14 | 24 | 58.3% | 7 | 11 | 63.6% | 3 | 6 | 50.0% | 6.0 |
| 2025-12-26 | ORL vs. CHA | L | 36.3 | 24 | 3 | 4 | 2 | 1 | 2 | 8 | 17 | 47.1% | 4 | 7 | 57.1% | 4 | 4 | 100.0% | -19.0 |
| 2025-12-23 | ORL @ POR | W | 32.5 | 22 | 7 | 6 | 2 | 0 | 3 | 8 | 21 | 38.1% | 4 | 8 | 50.0% | 2 | 3 | 66.7% | 10.0 |
| 2025-12-22 | ORL @ GSW | L | 30.5 | 19 | 6 | 3 | 0 | 1 | 2 | 8 | 12 | 66.7% | 2 | 5 | 40.0% | 1 | 3 | 33.3% | -16.0 |
| 2025-12-20 | ORL @ UTA | W | 39.6 | 20 | 6 | 5 | 0 | 0 | 1 | 6 | 12 | 50.0% | 1 | 4 | 25.0% | 7 | 8 | 87.5% | -3.0 |
| 2025-12-18 | ORL @ DEN | L | 37.4 | 22 | 2 | 3 | 2 | 0 | 3 | 8 | 18 | 44.4% | 2 | 6 | 33.3% | 4 | 6 | 66.7% | -5.0 |
| 2025-12-13 | ORL @ NYK | L | 36.5 | 12 | 8 | 4 | 1 | 2 | 4 | 5 | 15 | 33.3% | 1 | 6 | 16.7% | 1 | 3 | 33.3% | -3.0 |
| 2025-12-09 | ORL vs. MIA | W | 34.0 | 10 | 3 | 7 | 1 | 1 | 2 | 5 | 15 | 33.3% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-12-07 | ORL @ NYK | L | 30.5 | 14 | 11 | 4 | 0 | 1 | 4 | 6 | 16 | 37.5% | 1 | 7 | 14.3% | 1 | 1 | 100.0% | -5.0 |
| 2025-12-05 | ORL vs. MIA | W | 31.5 | 13 | 8 | 6 | 2 | 0 | 2 | 2 | 9 | 22.2% | 0 | 2 | 0.0% | 9 | 12 | 75.0% | 4.0 |
| 2025-12-03 | ORL vs. SAS | L | 27.6 | 7 | 7 | 5 | 0 | 0 | 2 | 2 | 10 | 20.0% | 0 | 2 | 0.0% | 3 | 4 | 75.0% | -2.0 |
| 2025-12-01 | ORL vs. CHI | W | 33.8 | 22 | 9 | 3 | 0 | 2 | 1 | 8 | 15 | 53.3% | 2 | 5 | 40.0% | 4 | 6 | 66.7% | 25.0 |
| 2025-11-28 | ORL @ DET | W | 31.5 | 16 | 4 | 4 | 3 | 1 | 3 | 6 | 17 | 35.3% | 1 | 4 | 25.0% | 3 | 6 | 50.0% | 27.0 |
| 2025-11-25 | ORL @ PHI | W | 27.9 | 31 | 1 | 3 | 1 | 0 | 3 | 12 | 17 | 70.6% | 4 | 6 | 66.7% | 3 | 4 | 75.0% | 31.0 |
| 2025-11-23 | ORL @ BOS | L | 27.5 | 14 | 3 | 5 | 1 | 0 | 2 | 4 | 13 | 30.8% | 2 | 4 | 50.0% | 4 | 5 | 80.0% | -23.0 |
| 2025-11-22 | ORL vs. NYK | W | 29.2 | 11 | 1 | 4 | 3 | 1 | 1 | 4 | 8 | 50.0% | 1 | 2 | 50.0% | 2 | 4 | 50.0% | 21.0 |
| 2025-11-20 | ORL vs. LAC | W | 29.3 | 12 | 4 | 4 | 4 | 0 | 2 | 4 | 9 | 44.4% | 1 | 3 | 33.3% | 3 | 4 | 75.0% | 16.0 |
| 2025-11-18 | ORL vs. GSW | W | 32.8 | 21 | 4 | 2 | 2 | 0 | 1 | 8 | 13 | 61.5% | 0 | 3 | 0.0% | 5 | 7 | 71.4% | 18.0 |
| 2025-11-16 | ORL @ HOU | L | 35.8 | 18 | 3 | 4 | 1 | 1 | 2 | 7 | 14 | 50.0% | 1 | 5 | 20.0% | 3 | 5 | 60.0% | 2.0 |
| 2025-11-14 | ORL vs. BKN | W | 16.6 | 2 | 0 | 2 | 0 | 0 | 1 | 1 | 4 | 25.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2025-11-12 | ORL @ NYK | W | 23.1 | 17 | 3 | 3 | 2 | 1 | 2 | 7 | 11 | 63.6% | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-11-10 | ORL vs. POR | W | 32.4 | 8 | 4 | 2 | 1 | 0 | 2 | 2 | 8 | 25.0% | 1 | 3 | 33.3% | 3 | 4 | 75.0% | -10.0 |
| 2025-11-09 | ORL vs. BOS | L | 19.8 | 4 | 3 | 0 | 1 | 0 | 1 | 2 | 6 | 33.3% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -25.0 |
| 2025-11-07 | ORL vs. BOS | W | 32.6 | 13 | 4 | 4 | 4 | 1 | 1 | 5 | 11 | 45.5% | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 6.0 |
| 2025-11-04 | ORL @ ATL | L | 26.1 | 7 | 4 | 3 | 1 | 1 | 1 | 2 | 7 | 28.6% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | -12.0 |
| 2025-11-01 | ORL @ WAS | W | 24.6 | 8 | 2 | 5 | 0 | 1 | 3 | 3 | 6 | 50.0% | 0 | 2 | 0.0% | 2 | 2 | 100.0% | 1.0 |
| 2025-10-30 | ORL @ CHA | W | 30.6 | 20 | 1 | 2 | 2 | 2 | 3 | 8 | 13 | 61.5% | 3 | 6 | 50.0% | 1 | 1 | 100.0% | 8.0 |
| 2025-10-29 | ORL @ DET | L | 24.0 | 10 | 4 | 1 | 1 | 0 | 2 | 3 | 10 | 30.0% | 1 | 6 | 16.7% | 3 | 4 | 75.0% | -28.0 |
| 2025-10-27 | ORL @ PHI | L | 29.8 | 14 | 3 | 2 | 1 | 1 | 3 | 5 | 10 | 50.0% | 1 | 3 | 33.3% | 3 | 7 | 42.9% | -4.0 |
| 2025-10-25 | ORL vs. CHI | L | 29.7 | 19 | 5 | 1 | 1 | 1 | 5 | 6 | 9 | 66.7% | 1 | 3 | 33.3% | 6 | 6 | 100.0% | 4.0 |
| 2025-10-24 | ORL vs. ATL | L | 21.0 | 8 | 3 | 2 | 1 | 0 | 4 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 2 | 5 | 40.0% | 2.0 |
| 2025-10-22 | ORL vs. MIA | W | 23.3 | 7 | 3 | 3 | 0 | 1 | 0 | 3 | 9 | 33.3% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 13.0 |